This site is intended for U.S. health care professionals.
Scroll for Important Safety Information and Indications
- Prevnar 13® is a vaccine indicated for active immunization for the prevention of disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F
- In children 6 weeks through 17 years for invasive disease caused by the 13 serotypes, and for children 6 weeks through 5 years of age for otitis media caused by 7 of the 13 serotypes only (4, 6B, 9V, 14, 18C, 19F, and 23F)
- Prevnar 13® will only help protect against S. pneumoniae serotypes in the vaccine
- Severe allergic reaction (eg, anaphylaxis) to any component of
Prevnar 13® or any diphtheria toxoid–containing vaccine is a contraindication - Immunocompromised individuals or individuals with impaired immune responsiveness due to the use of immunosuppressive therapy may have reduced antibody response
- Apnea following intramuscular vaccination has been observed in some infants born prematurely. Vaccination of premature infants should be based on the infant's medical status, and the potential benefits and risks
- In infants and toddlers, the most commonly reported serious adverse events were bronchiolitis (0.9%), gastroenteritis (0.9%), and pneumonia (0.9%)
- In children 6 weeks through 17 years, the most commonly reported solicited adverse reactions were injection site tenderness, redness, or swelling, irritability, decreased appetite, decreased or increased sleep, and fever
- In children 6 years through 17 years of age, Prevnar 13® is administered as a single dose
- Prevnar 13® is a vaccine indicated for active immunization for the prevention of disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F
- In children 6 weeks through 17 years for invasive disease caused by the 13 serotypes, and for children 6 weeks through 5 years of age for otitis media caused by 7 of the 13 serotypes only (4, 6B, 9V, 14, 18C, 19F, and 23F)
- Prevnar 13® will only help protect against S. pneumoniae serotypes in the vaccine
Reference:
1.
Resources
BabyVaxFacts
www.babyvaxfacts.com
American Academy of Pediatrics
www.aap.org
American Academy of Family Physicians
www.aafp.org
American Nurses Association
www.nursingworld.org
Association for Early Learning Leaders
www.earlylearningleaders.org
Every Child By Two
www.ecbt.org
The History of Vaccines
www.historyofvaccines.org
Immunization Action Coalition
www.immunize.org
Public Health
www.publichealth.org
Infectious Diseases Society of America
www.idsociety.org
National Association of Pediatric Nurse Practitioners
www.napnap.org
National Healthy Mothers, Healthy Babies Coalition
www.hmhb.org
Society of Teachers of Family Medicine, Group on Immunization Education
www.immunizationed.org
Text4Baby®
www.text4baby.org
Vaccines and Immunizations
www.cdc.gov/vaccines